Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    11490233 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Doxazosin 4 mg daily plus Celecoxib 200 mg every day (QD);   Drug: Doxazosin 4 mg every day (QD)

Study has passed its completion date and status has not been verified in more than two years.